{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:19:18Z","timestamp":1794669558414,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T00:00:00Z","timestamp":1385337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-0500-6-487","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:50:18Z","timestamp":1385427018000},"source":"Crossref","is-referenced-by-count":55,"title":["Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal"],"prefix":"10.1186","volume":"6","author":[{"given":"Anil","family":"Chander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrika Devi","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,25]]},"reference":[{"issue":"16","key":"2500_CR1","first-page":"3921","volume":"8","author":"F Ullah","year":"2009","unstructured":"Ullah F, Malik SA, Ahmed J: Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol. 2009, 8 (16): 3921-3926.","journal-title":"Afr J Biotechnol"},{"issue":"3","key":"2500_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0090-4295(88)90386-X","volume":"32","author":"CE Cox","year":"1988","unstructured":"Cox CE: Nosocomial urinary tract infections. Urol. 1988, 32 (3): 210-215. 10.1016\/0090-4295(88)90386-X.","journal-title":"Urol"},{"issue":"6","key":"2500_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s003450050163","volume":"17","author":"CM Gonzalez","year":"1999","unstructured":"Gonzalez CM, Schaeffer AJ: Treatment of urinary tract infection: what\u2019s old, what\u2019s new, and what works. World J Urol. 1999, 17 (6): 372-382. 10.1007\/s003450050163.","journal-title":"World J Urol"},{"issue":"47","key":"2500_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.47.19044-en","volume":"13","author":"TM Coque","year":"2008","unstructured":"Coque TM, Baquero F, Canton R: Increasing prevalence of ESBL producing enterobacteriaceae in Europe. Eurosurveillance. 2008, 13 (47): 1-11.","journal-title":"Eurosurveillance"},{"issue":"4","key":"2500_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA: Extended spectrum \u03b2-lactamases: a clinical update. Clin Microbiol Rev. 2005, 18 (4): 657-686. 10.1128\/CMR.18.4.657-686.2005.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"2500_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"PA Bradford","year":"2001","unstructured":"Bradford PA: Extended spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001, 14 (4): 933-951. 10.1128\/CMR.14.4.933-951.2001.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"2500_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMra041359","volume":"352","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA, Munoz-Price LS: The new beta-lactamases. New Engl J Med. 2005, 352 (4): 380-391. 10.1056\/NEJMra041359.","journal-title":"New Engl J Med"},{"issue":"4","key":"2500_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00003495-200363040-00002","volume":"63","author":"ME Rupp","year":"2003","unstructured":"Rupp ME, Fey PD: Extended spectrum \u03b2-lactamase (ESBL)- producing enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs. 2003, 63 (4): 353-365. 10.2165\/00003495-200363040-00002.","journal-title":"Drugs"},{"key":"2500_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7326\/0003-4819-119-5-199309010-00001","volume":"119","author":"KS Meyer","year":"1993","unstructured":"Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ: Nosocomial outbeak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med. 1993, 119: 353-358. 10.7326\/0003-4819-119-5-199309010-00001.","journal-title":"Ann Intern Med"},{"key":"2500_CR10","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1128\/AAC.36.9.1991","volume":"36","author":"L Naumovsky","year":"1992","unstructured":"Naumovsky L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, et al: Outbreak of ceftazidime resistance due to a novel extended spectrum \u03b2-lactamase in isolates from cancer patients. Antimicrob Agents Chemother. 1992, 36: 1991-1996. 10.1128\/AAC.36.9.1991.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/174.3.529","volume":"174","author":"DA Schiappa","year":"1996","unstructured":"Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al: Ceftazidime resistant Klebsiella pneumoniae and Escherichia coli blood stream infection: a case control and molecular epidemiologic investigation. J Infect Dis. 1996, 174: 529-536. 10.1093\/infdis\/174.3.529.","journal-title":"J Infect Dis"},{"key":"2500_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/313719","volume":"30","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Mulazimoglu L, Casellas JM, Ko W-C, Goossens H, Gottberg AV, et al: Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum \u03b2-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000, 30: 473-478. 10.1086\/313719.","journal-title":"Clin Infect Dis"},{"key":"2500_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1128\/AAC.46.1.196-202.2002","volume":"46","author":"T Spanu","year":"2002","unstructured":"Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G: The Italian ESBL Study Group. Occurrence of extended spectrum \u03b2-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to \u03b2-lactams and other antimicrobial drugs. Antimicrob Agents Chemother. 2002, 46: 196-202. 10.1128\/AAC.46.1.196-202.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1128\/AAC.35.1.164","volume":"35","author":"GA Jacoby","year":"1991","unstructured":"Jacoby GA, Sutton L: Properties of plasmids responsible for production of extended spectrum \u03b2-lactamases. Antimicrob Agents Chemother. 1991, 35: 164-169. 10.1128\/AAC.35.1.164.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1128\/AAC.44.3.622-632.2000","volume":"44","author":"M Poirel","year":"2000","unstructured":"Poirel M, Le Thomas I, Naas T, Karim A, Nordmann P: Biochemical sequence analyses of GES-1, a novel class A extended spectrum \u03b2-lactamase, and the Class I integrin In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother. 2000, 44: 622-632. 10.1128\/AAC.44.3.622-632.2000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2500_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","volume":"48","author":"R Bonnet","year":"2004","unstructured":"Bonnet R: Growing group of extended spectrum \u03b2-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004, 48 (1): 1-14. 10.1128\/AAC.48.1.1-14.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2500_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","volume":"73","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Karageorgopoulos: Extended spectrum \u03b2-lactamase-producing organisms. J Hosp Infect. 2009, 73 (4): 345-354. 10.1016\/j.jhin.2009.02.021.","journal-title":"J Hosp Infect"},{"issue":"5","key":"2500_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/jac\/dkm310","volume":"60","author":"RR Reinert","year":"2007","unstructured":"Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ: Antimicrobial susceptibility among organisms from the Asia\/ Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother. 2007, 60 (5): 1018-1029. 10.1093\/jac\/dkm310.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"2500_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1469-0691.2007.01869.x","volume":"14","author":"MV Villegas","year":"2008","unstructured":"Villegas MV, Kattan JN, Quinteros MG, Casselas JM: Prevalence of extended-spectrum \u03b2-lactamases in South America. Clin Microbiol Infect. 2008, 14 (Suppl. 1): 154-158.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2500_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1590\/S1413-86702004000100004","volume":"8","author":"HS Sader","year":"2004","unstructured":"Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC: SENTRY antimicrobial surveillance program report; Latin America and Brazilian results for 1997 through 2001. Braz J Infect Dis. 2004, 8 (1): 25-79. 10.1590\/S1413-86702004000100004.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"2500_CR21","first-page":"34","volume":"13","author":"S Poudyal","year":"2011","unstructured":"Poudyal S, Bhatta DR, Shakya G, Upadhyaya B, Dumre SP, Buda G, et al: Extended spectrum \u03b2-lactamase producing multidrug resistant clinical bacterial isolates at National Public Health Laboratory, Nepal. Nepal Med Coll J. 2011, 13 (1): 34-38.","journal-title":"Nepal Med Coll J"},{"issue":"3","key":"2500_CR22","first-page":"186","volume":"13","author":"S Shrestha","year":"2011","unstructured":"Shrestha S, Amatya R, Dutta R: Prevalence of extended spectrum beta lactamase (ESBL) production in gram negative isolates from pyogenic infection in tertiary care hospital of Eastern Nepal. Nepal Med Coll J. 2011, 13 (3): 186-189.","journal-title":"Nepal Med Coll J"},{"key":"2500_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-0500-5-38","volume":"5","author":"P Baral","year":"2012","unstructured":"Baral P, Neupane S, Marasini BP, Ghimire KR, Lekhak B, Shrestha B: High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. BMC Res Notes. 2012, 5: 38-10.1186\/1756-0500-5-38.","journal-title":"BMC Res Notes"},{"key":"2500_CR24","first-page":"131","volume-title":"Mackie and McCartney Practical Medical Microbiology","author":"JG Collee","year":"1996","unstructured":"Collee JG, Miles RS, Watt B: Tests for identification of bacteria. Mackie and McCartney Practical Medical Microbiology. Edited by: Collee JG, Fraser AG, Marmion BP, Simmons A. 1996, New York: Churchill Livingstone, 131-149. 14","edition":"14"},{"key":"2500_CR25","volume-title":"Performance standards for antimicrobial susceptibility testing; Twenty First informational supplement (M 100-S21)","author":"Clinical Laboratory Standards Institute","year":"2011","unstructured":"Clinical Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; Twenty First informational supplement (M 100-S21). 2011, Wayne PA: Clinical and Laboratory Standards Institute"},{"key":"2500_CR26","first-page":"584","volume":"99","author":"TM Habte","year":"2009","unstructured":"Habte TM, Dube S, Ismail N, Hoosen AA: Hospital and community isolates of uropathogens at a tertiary hospital in South Africa. S Afr Med J. 2009, 99: 584-587.","journal-title":"S Afr Med J"},{"key":"2500_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ijantimicag.2003.10.003","volume":"23","author":"AJ Matute","year":"2004","unstructured":"Matute AJ, Hak E, Schurink CAM, McArthur A, Alonso E, Pantagua M, et al: Resistance of uropathogens in symptomatic urinary tract infections in Leon, Nicaragua. Int J Antimicrob Agents. 2004, 23: 506-509. 10.1016\/j.ijantimicag.2003.10.003.","journal-title":"Int J Antimicrob Agents"},{"key":"2500_CR28","first-page":"1562","volume":"5","author":"DH Tambekar","year":"2006","unstructured":"Tambekar DH, Dhanorkar DV, Gulhane DR, Khanadelwal VK, Dudhane MN: Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics. Afr J Biotechnol. 2006, 5: 1562-1565.","journal-title":"Afr J Biotechnol"},{"key":"2500_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/10766290152045048","volume":"7","author":"R Durmaz","year":"2001","unstructured":"Durmaz R, Durmaz B, Koroglu M, Tekerekoglu MS: Detection and typing of extended- spectrum \u03b2-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey. Microb Drug Resist. 2001, 7: 171-175. 10.1089\/10766290152045048.","journal-title":"Microb Drug Resist"},{"key":"2500_CR30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0255-0857(21)02830-9","volume":"22","author":"S Babypadmini","year":"2004","unstructured":"Babypadmini S, Appalaraju B: Extended spectrum lactamase in urinary isolates of E.coli and Klebsiella pneumoniae - prevalence and susceptibility patterns in a tertiary care hospital. Indian J Med Microbiol. 2004, 22: 172-174.","journal-title":"Indian J Med Microbiol"},{"key":"2500_CR31","first-page":"197","volume":"2","author":"Z Aminzadeh","year":"2008","unstructured":"Aminzadeh Z, Sadat KM, Sha\u2019bani M: Bacteriuria by extended spectrum beta-lactamase producing E.coli and Klebsiella pneumoniae isolates in a government hospital in south of Tehran, Iran. Iran J Kidney Dis. 2008, 2: 197-200.","journal-title":"Iran J Kidney Dis"},{"key":"2500_CR32","first-page":"1192","volume":"6","author":"SM Ahmed","year":"2012","unstructured":"Ahmed SM, Jakribettu RP, Koyakutty S, Arya B, Shakir VPA: Urinary tract infections \u2013 an overview on the prevalence and the anti-biogram of gram negative uropathogens in a tertiary care center in North Kerala, India. J Clin Diagn Res. 2012, 6: 1192-1195.","journal-title":"J Clin Diagn Res"},{"key":"2500_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4297\/najms.2011.375","volume":"3","author":"BH Oladeinde","year":"2011","unstructured":"Oladeinde BH, Omoregie R, Olley M, Anunibe JE: Urinary tract infections in a rural community of Nigeria. North Amer J Med Sci. 2011, 3: 75-77.","journal-title":"North Amer J Med Sci"},{"issue":"4","key":"2500_CR34","first-page":"645","volume":"6","author":"G Dalela","year":"2012","unstructured":"Dalela G, Gupta S, Jain DK, Mehta P: Antibiotic resistance patterns in uropathogens at a tertiary care hospital at Jhalawar with special reference to ESBL, AmpC b-lactamase and MRSA production. J Clin Diagn Res. 2012, 6 (4): 645-651.","journal-title":"J Clin Diagn Res"},{"key":"2500_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/dkl466","volume":"59","author":"F Randrianirina","year":"2007","unstructured":"Randrianirina F, Soares J-L, Carod J-F, Ratsima E, Thonnier V, Combe P, et al: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother. 2007, 59: 309-312.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2500_CR36","first-page":"881","volume":"4","author":"A Behrooozi","year":"2010","unstructured":"Behrooozi A, Rahbar M, Yousefi JV: Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res. 2010, 4 (9): 881-884.","journal-title":"Afr J Microbiol Res"},{"key":"2500_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/IDR.S30043","volume":"5","author":"A Pathak","year":"2012","unstructured":"Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS: High prevalence of extended spectrum \u03b2-lactamase producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist. 2012, 5: 65-73.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2500_CR38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3329\/bjmm.v4i1.8467","volume":"4","author":"I Alipourfard","year":"2010","unstructured":"Alipourfard I, Nili NY: Antibiogram of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from hospital samples. Bangladesh J Med Microbiol. 2010, 4 (1): 32-36.","journal-title":"Bangladesh J Med Microbiol"},{"issue":"10","key":"2500_CR39","doi-asserted-by":"publisher","first-page":"e47707","DOI":"10.1371\/journal.pone.0047707","volume":"7","author":"CFM van der Donk","year":"2012","unstructured":"van der Donk CFM, van de Bovenkamp JHB, De Brauwer EIGB, De Mol P, Feldhoff K-H, Kalka-Moll WM, et al: Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the Euregion Meuse-Rhine. PLoS One. 2012, 7 (10): e47707-10.1371\/journal.pone.0047707.","journal-title":"PLoS One"},{"issue":"1","key":"2500_CR40","first-page":"11","volume":"26","author":"FE Abdullah","year":"2013","unstructured":"Abdullah FE, Mushtaq A, Irshad M, Rauf H, Afzal N, Rasheed A: Current efficacy of antibiotics against Klebsiella isolates from urine samples \u2013 a multi-centric experience in Karachi. Pak J Pharm Sci. 2013, 26 (1): 11-15.","journal-title":"Pak J Pharm Sci"},{"issue":"8","key":"2500_CR41","first-page":"1811","volume":"58","author":"LS Gonzalez","year":"1998","unstructured":"Gonzalez LS, Spencer JP: Aminoglycosides: a practical review. Am Fam Physician. 1998, 58 (8): 1811-1820.","journal-title":"Am Fam Physician"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-6-487\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T12:12:13Z","timestamp":1647519133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,25]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2500"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-487","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,25]]},"article-number":"487"}}